The Patient and Clinician Assessment of Gastrointestinal (GI) Related Adverse Events Associated with Oral Disease-Modifying Therapies in Multiple Sclerosis: A Qualitative Study

INTRODUCTION: Current guidelines for relapsing-remitting multiple sclerosis (RRMS) call for treatment with disease-modifying therapies (DMTs) early in the disease to prevent relapses and accumulation of neurologic impairment and disability. However, patients taking certain oral DMTs may experience g...

Descripción completa

Detalles Bibliográficos
Autores principales: Jivraj, Farah, Kang, Sha, Reedie, Scott, Kapadia, Shivani, Strzok, Sara, Elliott, Emma, Cano, Stefan, Rock, Marvin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438375/
https://www.ncbi.nlm.nih.gov/pubmed/36053450
http://dx.doi.org/10.1007/s12325-022-02250-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438375/
https://www.ncbi.nlm.nih.gov/pubmed/36053450
http://dx.doi.org/10.1007/s12325-022-02250-x

Ejemplares similares